2020
DOI: 10.1007/s40271-020-00423-w
|View full text |Cite
|
Sign up to set email alerts
|

Feasibility of Measuring Preferences for Chemotherapy Among Early-Stage Breast Cancer Survivors Using a Direct Rank Ordering Multicriteria Decision Analysis Versus a Time Trade-Off

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 33 publications
0
1
0
Order By: Relevance
“…Camps et al [9] Assessment and prioritization of the WHO "best buys" and other recommended interventions for the prevention and control of non-communicable diseases in Iran Bakhtiari et al [5] Benefit and risk of Tripterygium Glycosides Tablets in treatment of rheumatoid arthritis based on multi-criteria decision-making analysis Jiang et al [29] Multiple criteria decision analysis approach to consider therapeutic innovations in the emergency department: The methoxyflurane organizational impact in acute trauma pain Lvovschi et al [39] Feasibility of Measuring Preferences for Chemotherapy Among Early-Stage Breast Cancer Survivors Using a Direct Rank Ordering Multicriteria Decision Analysis Versus a Time Trade-Off Panattoni et al [48] Assessing the Preferences for Criteria in Multi-Criteria Decision Analysis in Treatments for Rare Disease Schey et al [54] 'It takes two to tango': Bridging the gap between country need and vaccine product innovation Archer et al [4] terms, wording and how to conduct MCDA in healthcare settings; implementation of different MCDA techniques as much as possible; mutual comparison of different MCDA methods on the same topic. The most important is to involve in all these researches not only all interested parties rather all possibly involved and impacted parties in decision making process (eg.…”
Section: Development Of a Multicriteria Decision Analysis Framework F...mentioning
confidence: 99%
“…Camps et al [9] Assessment and prioritization of the WHO "best buys" and other recommended interventions for the prevention and control of non-communicable diseases in Iran Bakhtiari et al [5] Benefit and risk of Tripterygium Glycosides Tablets in treatment of rheumatoid arthritis based on multi-criteria decision-making analysis Jiang et al [29] Multiple criteria decision analysis approach to consider therapeutic innovations in the emergency department: The methoxyflurane organizational impact in acute trauma pain Lvovschi et al [39] Feasibility of Measuring Preferences for Chemotherapy Among Early-Stage Breast Cancer Survivors Using a Direct Rank Ordering Multicriteria Decision Analysis Versus a Time Trade-Off Panattoni et al [48] Assessing the Preferences for Criteria in Multi-Criteria Decision Analysis in Treatments for Rare Disease Schey et al [54] 'It takes two to tango': Bridging the gap between country need and vaccine product innovation Archer et al [4] terms, wording and how to conduct MCDA in healthcare settings; implementation of different MCDA techniques as much as possible; mutual comparison of different MCDA methods on the same topic. The most important is to involve in all these researches not only all interested parties rather all possibly involved and impacted parties in decision making process (eg.…”
Section: Development Of a Multicriteria Decision Analysis Framework F...mentioning
confidence: 99%